Loading...

Celanese

NYSE:CE
Snowflake Description

Established dividend payer with proven track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CE
NYSE
$13B
Market Cap
  1. Home
  2. US
  3. Materials
Company description

Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The last earnings update was 27 days ago. More info.


Add to Portfolio Compare Print
CE Share Price and Events
7 Day Returns
2.5%
NYSE:CE
-0.6%
US Chemicals
-0.7%
US Market
1 Year Returns
-11.4%
NYSE:CE
-15.4%
US Chemicals
3%
US Market
CE Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Celanese (CE) 2.5% -3.4% 0.7% -11.4% 45.1% 66.1%
US Chemicals -0.6% -7.8% -8.9% -15.4% 16.9% 6.7%
US Market -0.7% -2% 2.4% 3% 39.2% 42%
1 Year Return vs Industry and Market
  • CE outperformed the Chemicals industry which returned -15.4% over the past year.
  • CE underperformed the Market in United States of America which returned 3% over the past year.
Price Volatility
CE
Industry
5yr Volatility vs Market

Value

 Is Celanese undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Celanese to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Celanese.

NYSE:CE Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 16 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 9%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NYSE:CE
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.87
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.87 (1 + (1- 21%) (30.31%))
1.053
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.05
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.053 * 5.96%)
9%

Discounted Cash Flow Calculation for NYSE:CE using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Celanese is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NYSE:CE DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 9%)
2019 1,159.14 Analyst x8 1,063.40
2020 1,180.33 Analyst x8 993.40
2021 1,243.00 Analyst x3 959.74
2022 1,221.76 Est @ -1.71% 865.43
2023 1,217.16 Est @ -0.38% 790.96
2024 1,223.92 Est @ 0.56% 729.66
2025 1,238.70 Est @ 1.21% 677.48
2026 1,259.31 Est @ 1.66% 631.87
2027 1,284.30 Est @ 1.98% 591.18
2028 1,312.66 Est @ 2.21% 554.33
Present value of next 10 years cash flows $7,857.46
NYSE:CE DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $1,312.66 × (1 + 2.73%) ÷ (9% – 2.73%)
$21,496.72
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $21,496.72 ÷ (1 + 9%)10
$9,077.95
NYSE:CE Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $7,857.46 + $9,077.95
$16,935.40
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $16,935.40 / 126.61
$133.76
NYSE:CE Discount to Share Price
Calculation Result
Value per share (USD) From above. $133.76
Current discount Discount to share price of $101.64
= -1 x ($101.64 - $133.76) / $133.76
24%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Celanese is available for.
Intrinsic value
24%
Share price is $101.64 vs Future cash flow value of $133.76
Current Discount Checks
For Celanese to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Celanese's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Celanese's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Celanese's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Celanese's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NYSE:CE PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in USD $8.96
NYSE:CE Share Price ** NYSE (2019-05-17) in USD $101.64
United States of America Chemicals Industry PE Ratio Median Figure of 67 Publicly-Listed Chemicals Companies 17.88x
United States of America Market PE Ratio Median Figure of 3,088 Publicly-Listed Companies 17.89x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Celanese.

NYSE:CE PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:CE Share Price ÷ EPS (both in USD)

= 101.64 ÷ 8.96

11.34x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Celanese is good value based on earnings compared to the US Chemicals industry average.
  • Celanese is good value based on earnings compared to the United States of America market.
Price based on expected Growth
Does Celanese's expected growth come at a high price?
Raw Data
NYSE:CE PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 11.34x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 16 Analysts
8.1%per year
United States of America Chemicals Industry PEG Ratio Median Figure of 49 Publicly-Listed Chemicals Companies 1.33x
United States of America Market PEG Ratio Median Figure of 2,117 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

NYSE:CE PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 11.34x ÷ 8.1%

1.41x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Celanese is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Celanese's assets?
Raw Data
NYSE:CE PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in USD $24.07
NYSE:CE Share Price * NYSE (2019-05-17) in USD $101.64
United States of America Chemicals Industry PB Ratio Median Figure of 93 Publicly-Listed Chemicals Companies 2.09x
United States of America Market PB Ratio Median Figure of 5,195 Publicly-Listed Companies 1.83x
NYSE:CE PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:CE Share Price ÷ Book Value per Share (both in USD)

= 101.64 ÷ 24.07

4.22x

* Primary Listing of Celanese.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Celanese is overvalued based on assets compared to the US Chemicals industry average.
X
Value checks
We assess Celanese's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Celanese has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Celanese expected to perform in the next 1 to 3 years based on estimates from 16 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
8.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Celanese expected to grow at an attractive rate?
  • Celanese's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Celanese's earnings growth is positive but not above the United States of America market average.
  • Celanese's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NYSE:CE Future Growth Rates Data Sources
Data Point Source Value (per year)
NYSE:CE Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 16 Analysts 8.1%
NYSE:CE Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 16 Analysts 5.4%
United States of America Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 13.1%
United States of America Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 4.3%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.9%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NYSE:CE Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 16 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NYSE:CE Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 7,820 1,677 1,513 10
2020-12-31 7,374 1,591 1,418 16
2019-12-31 6,987 1,547 1,315 16
NYSE:CE Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-03-31 6,991 1,722 1,185
2018-12-31 7,155 1,558 1,212
2018-09-30 7,059 1,253 1,320
2018-06-30 6,854 1,041 1,143
2018-03-31 6,520 754 1,038
2017-12-31 6,140 803 856
2017-09-30 5,858 698 812
2017-06-30 5,615 747 847
2017-03-31 5,456 798 829
2016-12-31 5,389 893 902
2016-09-30 5,412 1,076 444
2016-06-30 5,502 945 340

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Celanese's earnings are expected to grow by 8.1% yearly, however this is not considered high growth (20% yearly).
  • Celanese's revenue is expected to grow by 5.4% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NYSE:CE Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 16 Analyst Estimates (S&P Global) See Below

All data from Celanese Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:CE Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 12.17 12.68 11.66 2.00
2020-12-31 11.47 12.03 10.61 6.00
2019-12-31 10.31 10.53 9.93 5.00
NYSE:CE Past Financials Data
Date (Data in USD Millions) EPS *
2019-03-31 8.96
2018-12-31 9.02
2018-09-30 9.74
2018-06-30 8.41
2018-03-31 7.59
2017-12-31 6.21
2017-09-30 5.82
2017-06-30 6.00
2017-03-31 5.79
2016-12-31 6.22
2016-09-30 3.04
2016-06-30 2.30

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Celanese is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess Celanese's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Celanese has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Celanese performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Celanese's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Celanese's year on year earnings growth rate has been positive over the past 5 years.
  • Celanese's 1-year earnings growth exceeds its 5-year average (14.2% vs 6.5%)
  • Celanese's earnings growth has not exceeded the US Chemicals industry average in the past year (14.2% vs 14.2%).
Earnings and Revenue History
Celanese's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Celanese Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:CE Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 6,991.00 1,185.00 588.00 70.00
2018-12-31 7,155.00 1,212.00 606.00 72.00
2018-09-30 7,059.00 1,320.00 502.00 73.00
2018-06-30 6,854.00 1,143.00 508.00 74.00
2018-03-31 6,520.00 1,038.00 491.00 74.00
2017-12-31 6,140.00 856.00 451.00 73.00
2017-09-30 5,858.00 812.00 470.00 73.00
2017-06-30 5,615.00 847.00 441.00 74.00
2017-03-31 5,456.00 829.00 417.00 76.00
2016-12-31 5,389.00 902.00 416.00 78.00
2016-09-30 5,412.00 444.00 441.00 79.00
2016-06-30 5,502.00 340.00 453.00 78.00
2016-03-31 5,628.00 326.00 488.00 79.00
2015-12-31 5,674.00 306.00 506.00 80.00
2015-09-30 5,899.00 522.00 714.00 77.00
2015-06-30 6,255.00 619.00 739.00 80.00
2015-03-31 6,547.00 671.00 752.00 84.00
2014-12-31 6,802.00 631.00 758.00 86.00
2014-09-30 6,859.00 1,369.00 336.00 80.00
2014-06-30 6,726.00 1,282.00 315.00 82.00
2014-03-31 6,610.00 1,156.00 309.00 81.00
2013-12-31 6,510.00 1,101.00 311.00 85.00
2013-09-30 6,395.00 278.00 792.00 104.00
2013-06-30 6,368.00 236.00 808.00 103.00
2013-03-31 6,390.00 324.00 810.00 105.00
2012-12-31 6,418.00 376.00 830.00 104.00
2012-09-30 6,531.00 639.00 482.00 97.00
2012-06-30 6,729.00 677.00 509.00 98.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Whilst Celanese has efficiently used shareholders’ funds last year (Return on Equity greater than 20%), this is metric is skewed due to its high level of debt.
  • Celanese used its assets more efficiently than the US Chemicals industry average last year based on Return on Assets.
  • Celanese has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Celanese's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Celanese has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Celanese's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Celanese's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Celanese is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Celanese's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Celanese's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Celanese Company Filings, last reported 1 month ago.

NYSE:CE Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 3,439.00 3,901.00 447.00
2018-12-31 3,379.00 3,531.00 446.00
2018-09-30 3,943.00 3,425.00 707.00
2018-06-30 3,787.00 3,594.00 722.00
2018-03-31 3,665.00 3,768.00 504.00
2017-12-31 3,299.00 3,641.00 589.00
2017-09-30 3,135.00 3,389.00 469.00
2017-06-30 3,122.00 3,315.00 517.00
2017-03-31 3,041.00 2,958.00 519.00
2016-12-31 3,021.00 3,008.00 650.00
2016-09-30 3,151.00 3,015.00 1,264.00
2016-06-30 3,051.00 2,583.00 747.00
2016-03-31 3,098.00 2,603.00 729.00
2015-12-31 2,829.00 2,981.00 990.00
2015-09-30 3,197.00 3,005.00 981.00
2015-06-30 3,485.00 2,677.00 1,016.00
2015-03-31 3,199.00 2,667.00 879.00
2014-12-31 3,078.00 2,727.00 811.00
2014-09-30 3,135.00 3,409.00 1,540.00
2014-06-30 3,101.00 3,044.00 1,059.00
2014-03-31 2,920.00 3,044.00 1,008.00
2013-12-31 2,699.00 3,074.00 1,025.00
2013-09-30 2,084.00 3,107.00 1,144.00
2013-06-30 1,985.00 3,098.00 1,152.00
2013-03-31 1,835.00 3,090.00 1,027.00
2012-12-31 1,730.00 3,121.00 1,012.00
2012-09-30 1,915.00 3,007.00 984.00
2012-06-30 1,777.00 3,001.00 860.00
  • Celanese's level of debt (113.4%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (104.2% vs 113.4% today).
  • Debt is well covered by operating cash flow (44.1%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 1228x coverage).
X
Financial health checks
We assess Celanese's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Celanese has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Celanese's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
2.44%
Current annual income from Celanese dividends. Estimated to be 2.49% next year.
If you bought $2,000 of Celanese shares you are expected to receive $49 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Celanese's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).
  • Celanese's dividend is below the markets top 25% of dividend payers in United States of America (3.69%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NYSE:CE Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 16 Analyst Estimates (S&P Global) See Below
United States of America Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 54 Stocks 2.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2000 Stocks 2.5%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NYSE:CE Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2021-12-31 2.68 6.00
2020-12-31 2.58 10.00
2019-12-31 2.38 10.00
NYSE:CE Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-04-18 2.480 2.351
2019-02-06 2.160 2.133
2018-10-17 2.160 2.261
2018-07-16 2.160 1.912
2018-04-18 2.160 1.929
2018-02-08 1.840 1.785
2017-10-18 1.840 1.723
2017-07-17 1.840 1.841
2017-04-20 1.840 2.048
2017-02-09 1.440 1.600
2016-10-19 1.440 1.813
2016-07-20 1.440 2.217
2016-04-21 1.440 2.074
2016-02-04 1.200 1.891
2015-10-22 1.200 1.801
2015-07-21 1.200 1.925
2015-04-23 1.200 1.745
2015-02-06 1.000 1.734
2014-10-23 1.000 1.712
2014-07-24 1.000 1.694
2014-04-24 1.000 1.599
2014-02-07 0.720 1.324
2013-10-24 0.720 1.312
2013-07-25 0.720 1.416
2013-04-25 0.360 0.754
2013-02-07 0.300 0.655
2012-10-18 0.300 0.704
2012-04-23 0.300 0.771
2012-04-05 0.240 0.518
2012-01-05 0.240 0.504
2011-10-07 0.240 0.566
2011-04-25 0.240 0.520
2011-04-07 0.200 0.436
2011-01-06 0.200 0.473
2010-10-04 0.200 0.538
2010-04-26 0.200 0.707
2010-04-05 0.160 0.476
2010-01-05 0.160 0.503
2009-10-05 0.160 0.548
2009-07-06 0.160 0.640

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Celanese's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (4.1x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (4.6x coverage).
X
Income/ dividend checks
We assess Celanese's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Celanese afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Celanese has a total score of 5/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Celanese's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Lori Ryerkerk
AGE 55
TENURE AS CEO 0 years
CEO Bio

Ms. Lori J. Ryerkerk, BS, serves as Chief Executive Officer and Director of Celanese Corporation since May 1, 2019. She served as an Executive Vice President, Global Manufacturing for Royal Dutch Shell (Shell), based in the U.K. Ms. Ryerkerk was responsible for the operations of all Shell refining and chemical wholly owned and operated assets and joint ventures. She served as Managing Director and General Manager at ExxonMobil Energy Limited in Hong Kong. She served as Senior Vice President of Terminals, Supply and Refining at Hess Corporation. She served as Regional Vice President Manufacturing, Europe and Africa at Shell. She served as Senior Vice President of Hess Corporation since 2008. She has extensive experience in operations, technical and manufacturing in both petroleum refining and chemical industries within the United States. Ms. Ryerkerk was employed in senior managerial positions principally in the refining and marketing operations of ExxonMobil Energy Limited from 1991 to 2008. Her manufacturing positions included serving as Refinery Manager at the ExxonMobil Beaumont Refinery in Texas. She employed in treasury and financial functions at General Motors. She served as Senior Advisor of Safety, Health and Environment at ExxonMobil Corporation in Texas and Manufacturing Manager of Adhesion Industry-Americas for Exxon Chemicals in Louisiana. She had been Chairman of ExxonMobil Energy Limited since January 2003. She joined ExxonMobil Energy in April 2001. She serves as Chairman of the Board of Castle Peak Power Company Limited and Hong Kong Pumped Storage Development Co., Limited. She serves as a Director of CLP Power and CLP Research Institute Limited, a subsidiary of CLP Holdings Ltd. She has been a Director at Axalta Coating Systems Ltd. since October 2015. She has been Member of the Board of Advisors for Catalyst Inc., a national nonprofit that advocates for inclusive workplaces for women. She is Recipient of the Houston Business Journal’s Women in Energy Leadership Award. Ms. Ryerkerk received her B.S. in chemical engineering from Iowa State University.

CEO Compensation
  • Insufficient data for Lori to compare compensation growth.
  • Insufficient data for Lori to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Celanese management team in years:

1.4
Average Tenure
50
Average Age
  • The average tenure for the Celanese management team is less than 2 years, this suggests a new team.
Management Team

Mark Rohr

TITLE
Executive Chairman & President
COMPENSATION
$13M
AGE
67
TENURE
7.1 yrs

Scott Richardson

TITLE
Senior VP & CFO
COMPENSATION
$2M
AGE
41
TENURE
1.3 yrs

Shannon Jurecka

TITLE
Senior VP & Chief Human Resources Officer
COMPENSATION
$2M
AGE
48
TENURE
1.8 yrs

Kevin Oliver

TITLE
Chief Financial Officer for European Headquarters
COMPENSATION
$4M
AGE
46
TENURE
1.1 yrs

Lori Ryerkerk

TITLE
CEO & Director
AGE
55

Benita Casey

TITLE
Chief Accounting Officer
TENURE
1.1 yrs

Verghese Thomas

TITLE
VP and Chief Technology & Innovation Officer
TENURE
2.8 yrs

Surabhi Varshney

TITLE
Vice President of Investor Relations

Lynne Puckett

TITLE
Senior VP & General Counsel
TENURE
0.3 yrs

Mark Oberle

TITLE
Senior Vice President of EMEA & Asia
AGE
52
TENURE
1.5 yrs
Board of Directors Tenure

Average tenure and age of the Celanese board of directors in years:

5.3
Average Tenure
63
Average Age
  • The tenure for the Celanese board of directors is about average.
Board of Directors

Lori Ryerkerk

TITLE
CEO & Director
AGE
55

John Wulff

TITLE
Independent Director
COMPENSATION
$275K
AGE
69
TENURE
12.8 yrs

Mark Rohr

TITLE
Executive Chairman & President
COMPENSATION
$13M
AGE
67
TENURE
7.1 yrs

Jay Ihlenfeld

TITLE
Independent Director
COMPENSATION
$270K
AGE
66
TENURE
7.3 yrs

Jean Blackwell

TITLE
Independent Director
COMPENSATION
$270K
AGE
63
TENURE
5.3 yrs

Kathy Hill

TITLE
Independent Director
COMPENSATION
$275K
AGE
61
TENURE
3.8 yrs

Edward Galante

TITLE
Lead Independent Director
COMPENSATION
$285K
AGE
67
TENURE
2.3 yrs

David Hoffmeister

TITLE
Independent Director
COMPENSATION
$255K
AGE
63
TENURE
13.3 yrs

Bill Brown

TITLE
Independent Director
COMPENSATION
$255K
AGE
55
TENURE
3.3 yrs

Kim K. Rucker

TITLE
Director
COMPENSATION
$113K
AGE
51
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • Celanese insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
29. Apr 19 Sell John Wulff Individual 25. Apr 19 25. Apr 19 -9,175 $108.32 $-993,810
19. Jun 18 Sell Peter Edwards Individual 15. Jun 18 15. Jun 18 -3,674 $115.44 $-424,134
X
Management checks
We assess Celanese's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Celanese has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Do You Know What Celanese Corporation's (NYSE:CE) P/E Ratio Means?

The formula for price to earnings is: Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS) Or for Celanese: P/E of 11.53 = $103.36 ÷ $8.96 (Based on the trailing twelve months to March 2019.) Is A High Price-to-Earnings Ratio Good? … The P/E ratio indicates whether the market has higher or lower expectations of a company. … If the reality for a company is not as bad as the P/E ratio indicates, then the share price should increase as the market realizes this.

Simply Wall St -

Why Celanese Corporation (NYSE:CE) Is A Top Dividend Stock

Dividend paying stocks like Celanese Corporation (NYSE:CE) tend to be popular with investors, and for good reason - some research shows that a significant amount of all stock market returns come from reinvested dividends. … A 2.3% yield is nothing to get excited about, but investors probably think the long payment history suggests Celanese has some staying power. … The company also bought back stock during the year, equivalent to approximately 7.6% of the company's market capitalisation at the time.

Simply Wall St -

Should We Be Delighted With Celanese Corporation's (NYSE:CE) ROE Of 35%?

Our data shows Celanese has a return on equity of 35% for the last year. … That means that for every $1 worth of shareholders' equity, it generated $0.35 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Does Celanese Corporation's (NYSE:CE) CEO Salary Reflect Performance?

First, this article will compare CEO compensation with compensation at other large companies. … How Does Mark Rohr's Compensation Compare With Similar Sized Companies. … Our data indicates that Celanese Corporation is worth US$13b, and total annual CEO compensation is US$13m.

Simply Wall St -

Does Celanese's (NYSE:CE) Share Price Gain of 82% Match Its Business Performance?

To wit, the Celanese share price has climbed 82% in five years, easily topping the market return of 47% (ignoring dividends). … Over half a decade, Celanese managed to grow its earnings per share at 5.4% a year. … This EPS growth is slower than the share price growth of 13% per year, over the same period.

Simply Wall St -

Celanese Corporation (NYSE:CE): What Can We Expect From This High Growth Stock?

Celanese Corporation's (NYSE:CE) most recent earnings update in December 2018a … confirmed … business

Simply Wall St -

Celanese Corporation (NYSE:CE) Earns A Nice Return On Capital Employed

To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business. … What is Return On Capital Employed (ROCE)? … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.

Simply Wall St -

Want To Invest In Celanese Corporation (NYSE:CE)? Here's How It Performed Lately

When Celanese Corporation's (NYSE:CE) announced its latest earnings (31 December 2018), I wanted to understand how these figures stacked up against its past performance. … The two benchmarks I used were Celanese's average earnings over the past couple of years, and its industry performance. … CE's trailing twelve-month earnings (from 31 December 2018) of US$1.2b has.

Simply Wall St -

Estimating The Fair Value Of Celanese Corporation (NYSE:CE)

How far off is Celanese Corporation (NYSE:CE) from its intrinsic value? … by taking the expected future cash flows and discounting them to their present value. … Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

Simply Wall St -

Is Now The Time To Look At Buying Celanese Corporation (NYSE:CE)?

saw a decent share price growth in the teens level on the NYSE over the last few months. … With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price

Simply Wall St -

Company Info

Description

Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through Engineered Materials, Acetate Tow, and Acetyl Chain segments. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium, a sweetener for use in various beverages, confections, and dairy products; and food protection ingredients, such as potassium sorbate and sorbic acid for use in foods, beverages, and personal care products. The Acetate Tow segment provides acetate tows and flakes for use in filter products applications. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.

Details
Name: Celanese Corporation
CE
Exchange: NYSE
Founded: 1918
$12,868,893,686
126,612,492
Website: http://www.celanese.com
Address: Celanese Corporation
222 West Las Colinas Boulevard,
Suite 900N,
Irving,
Texas, 75039,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE CE Common Stock New York Stock Exchange US USD 21. Jan 2005
DB DG3 Common Stock Deutsche Boerse AG DE EUR 21. Jan 2005
LSE 0HUR Common Stock London Stock Exchange GB USD 21. Jan 2005
Number of employees
Current staff
Staff numbers
7,684
Celanese employees.
Industry
Specialty Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/05/20 01:58
End of day share price update: 2019/05/17 00:00
Last estimates confirmation: 2019/05/14
Last earnings filing: 2019/04/23
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.